For: | Xourgia E, Papazafiropoulou A, Melidonis A. Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron. World J Diabetes 2019; 10(3): 169-180 [PMID: 30891152 DOI: 10.4239/wjd.v10.i3.169] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v10/i3/169.htm |
Number | Citing Articles |
1 |
Lumei Liu, Neng Wang, Bill Kalionis, Shijin Xia, Qinghu He. HMGB1 plays an important role in pyroptosis induced blood brain barrier breakdown in diabetes-associated cognitive decline. Journal of Neuroimmunology 2022; 362: 577763 doi: 10.1016/j.jneuroim.2021.577763
|
2 |
Habib Yaribeygi, Milad Ashrafizadeh, Neil C. Henney, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar. Neuromodulatory effects of anti-diabetes medications: A mechanistic review. Pharmacological Research 2020; 152: 104611 doi: 10.1016/j.phrs.2019.104611
|
3 |
Noriko Shinjyo, James Parkinson, Jimmy Bell, Tatsuro Katsuno, Annie Bligh. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. Journal of Integrative Medicine 2020; 18(2): 125 doi: 10.1016/j.joim.2020.01.004
|
4 |
Jae-ho Jeong, Dong Hoon Lee, Juhyun Song. HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation. Biomedicine & Pharmacotherapy 2022; 150: 112933 doi: 10.1016/j.biopha.2022.112933
|
5 |
Carmen Hierro-Bujalance, Carmen Infante-Garcia, Angel del Marco, Marta Herrera, Maria Jose Carranza-Naval, Javier Suarez, Pilar Alves-Martinez, Simon Lubian-Lopez, Monica Garcia-Alloza. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes. Alzheimer's Research & Therapy 2020; 12(1) doi: 10.1186/s13195-020-00607-4
|
6 |
Isaac Oluwatobi Akefe, Victoria Aderonke Adegoke, Ibrahim Yusuf Lamidi, Matthew Phillip Ameh, Enokela Shaibu Idoga, Simon Azubuike Ubah, Itopa Etudaye Ajayi. Myrtenal mitigates streptozotocin-induced spatial memory deficit via improving oxido inflammatory, cholinergic and neurotransmitter functions in mice. Current Research in Pharmacology and Drug Discovery 2022; 3: 100106 doi: 10.1016/j.crphar.2022.100106
|
7 |
Isaac Oluwatobi Akefe, Ezekiel Stephen Nyan, Victoria Aderonke Adegoke, Ibrahim Yusuf Lamidi, Matthew Phillip Ameh, Uchendu Chidiebere, Simon Azubuike Ubah, Itopa Etudaye Ajayi. Myrtenal improves memory deficits in mice exposed to radiofrequency-electromagnetic radiation during gestational and neonatal development via enhancing oxido-inflammatory, and neurotransmitter functions. Heliyon 2023; 9(4): e15321 doi: 10.1016/j.heliyon.2023.e15321
|
8 |
Yane Costa Chaves, Karina Genaro, José Alexandre Crippa, Joice Maria da Cunha, Janaína Menezes Zanoveli. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease 2021; 36(4): 639 doi: 10.1007/s11011-020-00667-3
|
9 |
Wei Liu, Yi Zhou, Rui Liang, Yue Zhang. Inhibition of cyclin‐dependent kinase 5 activity alleviates diabetes‐related cognitive deficits. The FASEB Journal 2019; 33(12): 14506 doi: 10.1096/fj.201901292R
|
10 |
K. Sh. Magomedova, Yu. V. Bykov, V. A. Baturin. Diabetic ketoacidosis and cognitive impairment in children and adolescents. Bulletin of Siberian Medicine 2023; 22(3): 132 doi: 10.20538/1682-0363-2023-3-132-140
|
11 |
Punita Aggarwal, Faiz Khan, Sugato Banerjee. Metabolic Disorder Therapeutics and their Effects on Memory. CNS & Neurological Disorders - Drug Targets 2024; 23(9): 1061 doi: 10.2174/0118715273269329231013074613
|
12 |
Wenjie Zhang, Shihong Chen, Xianghua Zhuang. Research Progress on Lipocalin-2 in Diabetic Encephalopathy. Neuroscience 2023; 515: 74 doi: 10.1016/j.neuroscience.2023.02.011
|